News for Ainos, Inc. (AIMD)

AI Nose delivers accuracy and versatility, driving scalable growth across healthcare, industrial and robotics marketsTechnology, data moat, and strategic partne

Seven-Site Pilot Spanning Pharma, Facility Management, Energy and Utilities to Validate AI Nose as Next-Gen Industrial AI at ScaleRobots Gain a New Sense: AI No

Ainos (AIMD) has successfully met Nasdaq's minimum bid price requirement, ensuring its continued listing on the Nasdaq Capital Market. The confirmation coincide

Commercial Momentum Accelerates with Partnerships to Drive AI-Powered Scent Intelligence for IndustrialAI and HealthcareAI SAN DIEGO, CALIFORNIA / ACCESS Newswi

Ainos (NASDAQ:AIMD) is set to expand its AI-powered scent detection technology, AI Nose, into industrial markets with high-impact partnerships. Key part

Ainos Pioneers SmellTech as the Next Sensory Frontier in Industrial AI2H 2025 Industrial Pilots and Subscription Model Poised to Unlock Multi-Million Dollar Rev

Ainos (NASDAQ:AIMD) announces a strategic five-year partnership with Solomon Technology Corporation to expand its AI Nose platform throughout Asia.The partners

AI Nose and Smell Language Model Combine with Solomon's Vision AI to Power Multi-Sensory AutomationPartnership Accelerates AI Scent Intelligence Deployment in S

Trading for Ainos Inc. (AIMD) has been temporarily suspended as the company prepares to release significant news. Investors are eagerly awaiting updates that co

Ainos expands its partnership with ASE Technology for AI Nose deployment. Up to 15,000 AI Nose units to be deployed globally in a multi-phase rollout. Aino

Relationship Broadens Scope to Key ASE and SPIL Facilities with Multi-Phase DeploymentMilestone Positions ASEH and Ainos as First-Mover in AI-Powered Scent Inte

SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 26, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will implem

Effective June 30, 2025, Ainos (AIMD) will execute a 1-for-5 reverse stock split. The consolidation aims to attract institutional investors and ensure compl

Ainos Hits Inflection Point with AI Nose Pilot Ramp in Senior Care, Robotics, and SemiconductorsKey VELDONA® Human Clinical Studies Secure Taiwan Regulatory Gr

Ainos (AIMD) is advancing its footprint in both the healthcare and industrial sectors, starting with the pilot deployment of its AI Nose technology in Japan's s

Ainos (AIMD) recently shared a mid-year update for 2025, highlighting significant strategic achievements. The company has transitioned from research and develop

Ainos (AIMD) reports a 412% increase in Q1 revenue year-over-year. AI Nose technology achieves 85-90% accuracy in diverse applications. V

AI Nose Platform Advances Toward Scaled Pilot Programs Across Healthcare, Robotics, and IndustrialsVELDONA® Oral Interferon Receives Approval to Begin Human Tr

AI Nose accuracy in elderly care improved to 85% with additional Smell ID trainingAI-friendly healthcare policies to provide tailwinds for commercial rollout SA